BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 64 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,647,000 | -17.3% | 7,305,512 | -3.7% | 0.00% | 0.0% |
| Q3 2021 | $27,393,000 | +2.8% | 7,588,482 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $26,651,000 | -20.6% | 7,444,242 | -13.3% | 0.00% | 0.0% |
| Q1 2021 | $33,581,000 | -2.7% | 8,588,597 | +4.6% | 0.00% | 0.0% |
| Q4 2020 | $34,502,000 | +23.0% | 8,214,641 | +9.3% | 0.00% | 0.0% |
| Q3 2020 | $28,044,000 | -18.1% | 7,518,619 | -4.2% | 0.00% | 0.0% |
| Q2 2020 | $34,222,000 | +26.1% | 7,849,019 | +9.6% | 0.00% | 0.0% |
| Q1 2020 | $27,148,000 | -41.2% | 7,163,339 | -1.9% | 0.00% | -50.0% |
| Q4 2019 | $46,164,000 | +96.2% | 7,304,342 | +30.7% | 0.00% | +100.0% |
| Q3 2019 | $23,526,000 | -8.0% | 5,588,168 | +1.6% | 0.00% | 0.0% |
| Q2 2019 | $25,568,000 | +230.9% | 5,498,457 | +277.2% | 0.00% | – |
| Q1 2019 | $7,726,000 | +50.4% | 1,457,836 | +5.0% | 0.00% | – |
| Q4 2018 | $5,137,000 | +53.1% | 1,388,297 | +15.8% | 0.00% | – |
| Q3 2018 | $3,356,000 | -4.4% | 1,198,789 | +0.7% | 0.00% | – |
| Q2 2018 | $3,512,000 | +34.6% | 1,190,286 | +2.7% | 0.00% | – |
| Q1 2018 | $2,609,000 | -24.0% | 1,159,295 | -0.4% | 0.00% | – |
| Q4 2017 | $3,435,000 | +0.7% | 1,164,459 | +0.7% | 0.00% | – |
| Q3 2017 | $3,411,000 | +5.1% | 1,156,255 | -0.2% | 0.00% | – |
| Q2 2017 | $3,244,000 | +40.1% | 1,158,930 | -4.9% | 0.00% | – |
| Q1 2017 | $2,315,000 | +25622.2% | 1,218,839 | +41755.7% | 0.00% | – |
| Q1 2016 | $9,000 | +125.0% | 2,912 | +221.4% | 0.00% | – |
| Q4 2015 | $4,000 | -20.0% | 906 | 0.0% | 0.00% | – |
| Q3 2015 | $5,000 | -28.6% | 906 | 0.0% | 0.00% | – |
| Q2 2015 | $7,000 | -36.4% | 906 | -15.2% | 0.00% | – |
| Q1 2015 | $11,000 | -15.4% | 1,068 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | -27.8% | 1,068 | 0.0% | 0.00% | – |
| Q3 2014 | $18,000 | +38.5% | 1,068 | 0.0% | 0.00% | – |
| Q2 2014 | $13,000 | +62.5% | 1,068 | +13.6% | 0.00% | – |
| Q1 2014 | $8,000 | +33.3% | 940 | 0.0% | 0.00% | – |
| Q4 2013 | $6,000 | +50.0% | 940 | +43.5% | 0.00% | – |
| Q3 2013 | $4,000 | – | 655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenomic Capital Management LP | 1,188,759 | $3,685,000 | 0.79% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 4,339,837 | $13,453,000 | 0.40% |
| EMC Capital Management | 208,733 | $647,000 | 0.35% |
| Rubric Capital Management LP | 1,747,401 | $5,417,000 | 0.26% |
| Zebra Capital Management LLC | 50,887 | $158,000 | 0.25% |
| Hillsdale Investment Management Inc. | 1,184,300 | $3,672,000 | 0.25% |
| WEALTH EFFECTS LLC | 100,300 | $311,000 | 0.13% |
| SHEPHERD KAPLAN KROCHUK, LLC | 114,000 | $353,000 | 0.13% |
| Manteio Capital LLC | 23,879 | $74,000 | 0.10% |
| GLOBEFLEX CAPITAL L P | 273,162 | $846,000 | 0.09% |